Designed for patients who want to address weight, hormones, and metabolic health together
However, weight loss results vary from person to person
Im fact..using a 503b only means that the facility is INTENDING to produce and ship compounded medications in BULK across state lines
A 2025 study evaluating the short-term management of obesity found that subcutaneous Tirzepatide was cost-effective compared to both subcutaneous and oral semaglutide, with an incremental cost-effectiveness ratio (ICER) of $34,212 per quality-adjusted life-year (QALY) gained versus oral semaglutide, well below the common willingness-to-pay threshold of $150,000/QALY
9 Procedures like coronary stents, chemotherapy and even joint replacements were once exclusively inpatient but are now widely available in lower-cost settings
10.1002/mds.23148 301 SobeninI